Dr. Linday received her medical degree from the Columbia University College of Physicians and Surgeons (New York, NY). She trained at The New York Hospital, Cornell University Medical College (NY, NY), and at the St. Luke's-Roosevelt Hospital Center (NY, NY; a University Hospital of the Columbia University College of Physicians and Surgeons).

Dr. Linday is board-certified in pediatrics and pediatric cardiology, board-eligible in clinical pharmacology, and has additional fellowship training in child psychiatry. She is a Fellow of the American Academy of Pediatrics, where she is a member of the Section on Complementary, Holistic, and Integrative Medicine.  She is also a Fellow of the American College of Cardiology.

Currently, Dr. Linday is a Senior Attending in Pediatrics at the St. Luke's-Roosevelt Hospital Center (NY, NY), and a Consultant (former Associate Adjunct) in the Department of Otolaryngology of The New York Eye and Ear Infirmary (NY, NY). She is also an Assistant Clinical Professor of Pediatrics at Columbia University in the City of New York; an Adjunct Assistant Professor of Otolaryngology at New York Medical College (Valhalla, NY), and an Adjunct Research Scientist at the New York State Institute for Basic Research in Developmental Disabilities (Staten Island, NY). She has also been the Director of Medical Affairs and Associate Director of Cardiovascular Clinical Research at two different major U.S. pharmaceutical companies.

Dr. Linday is listed in Who’s Who in the East and Who’s Who in American Women.  She is a member of the American Society for Clinical Pharmacology and Therapeutics, the American Society for Pharmacology and Experimental Therapeutics, and the American Federation for Medical Research.  Dr. Linday is the author or co-author of over thirty articles in peer-reviewed medical journals or medical textbooks.

DISCLAIMER:

The information contained on this web site is provided for educational purposes only; it is a general reference for both health-care consumers and providers; it is not a prescription for any single individual. A high dose of famotidine (Pepcidâ) was used in the research discussed on this web site; treatment with this high dose should only be undertaken under the direction of your/your child's prescribing physician. Please print this information and bring it to your/your child's prescribing physician to determine whether this treatment is indicated for you/your child. Please be aware that the use of famotidine to treat children with autistic spectrum disorders is considered "off-label" use in the US because the US Food and Drug Administration has not specifically approved famotidine either for use in children or for the treatment of autistic spectrum disorders. This web site is not affiliated with Merck & Co., Inc. Any opinions expressed on this web site are Dr. Linday's, and do not necessarily reflect those of her affiliated institutions.

Go to Ear Infections, Cod Liver Oil, & Selenium

 

Updated June 23, 2010